Hypoxia Produces Pro-arrhythmic Late Sodium Current in Cardiac Myocytes by SUMOylation of NaV1.5 Channels. by Plant, Leigh D et al.
UC Irvine
UC Irvine Previously Published Works
Title
Hypoxia Produces Pro-arrhythmic Late Sodium Current in Cardiac Myocytes by 
SUMOylation of NaV1.5 Channels.
Permalink
https://escholarship.org/uc/item/5f70k5c6
Journal
Cell reports, 30(7)
ISSN
2211-1247
Authors
Plant, Leigh D
Xiong, Dazhi
Romero, Jesus
et al.
Publication Date
2020-02-01
DOI
10.1016/j.celrep.2020.01.025
License
https://creativecommons.org/licenses/by/4.0/ 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Cell Reports
ArticleHypoxia Produces Pro-arrhythmic
Late Sodium Current in Cardiac Myocytes
by SUMOylation of NaV1.5 Channels
Leigh D. Plant,1,* Dazhi Xiong,2 Jesus Romero,2 Hui Dai,2 and Steve A.N. Goldstein2,3,*
1Department of Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, Boston, MA 02115, USA
2Departments of Pediatrics and Physiology & Biophysics, University of California, Irvine, 1001 Health Sciences Road, Irvine Hall, Irvine, CA
92697, USA
3Lead Contact
*Correspondence: l.plant@northeastern.edu (L.D.P.), sgoldst2@uci.edu (S.A.N.G.)
https://doi.org/10.1016/j.celrep.2020.01.025SUMMARY
Acute cardiac hypoxia produces life-threatening
elevations in late sodium current (ILATE) in the human
heart. Here,we show the underlyingmechanism: hyp-
oxia induces rapid SUMOylation of NaV1.5 channels
so they reopen when normally inactive, late in the
action potential. NaV1.5 is SUMOylated only on lysine
442, and the mutation of that residue, or application
of a deSUMOylating enzyme, prevents hypoxic re-
openings. The time course of SUMOylation of single
channels in response to hypoxia coincides with the
increase in ILATE, a reaction that is complete in under
100 s. In human cardiac myocytes derived from
pluripotent stem cells, hypoxia-induced ILATE is
confirmed to be SUMO-dependent and to produce
action potential prolongation, the pro-arrhythmic
change observed in patients.INTRODUCTION
In the human heart, NaV1.5 voltage-gated sodium channels pass
INa, a rapidly activating and inactivating Na
+ current that deter-
mines the rise, duration, and timing of action potentials (Marba´n,
2002; Catterall, 1986). In addition, NaV1.5 channels pass a small,
persistent Na+ current, the late sodium current (ILATE), which con-
tributes to maintaining the action potential plateau (Makielski,
2016). In healthy hearts, ILATE is less than 0.5% of the magnitude
of peak INa and is passed by a small number of channels that do
not stay closed after inactivation (Makielski, 2016). In patients
with an ischemic and failing heart, sudden infant death syndrome
(SIDS), and mutations in SCN5A, the gene that encodes the
NaV1.5 channel, which produces long QT syndrome, the size
of ILATE can increase to 4%–5% of peak INa (Bennett et al.,
1995; Plant et al., 2006; Belardinelli et al., 2015). Furthermore,
acute hypoxia and ischemia have been recognized to increase
ILATE in cardiac myocytes (Saint et al., 1992; Ju et al., 1996; Car-
meliet, 1999; Belardinelli et al., 2006) prior to slower processes
like remodeling (West, 2017), and excess ILATE has been shown
to be pro-arrhythmic because it prolongs action potential dura-
tion (APD), reducing repolarization reserve, increasing suscepti-Cell Rep
This is an open access article under the CC BY-Nbility to after-depolarizations, and causing a predisposition to
torsades de pointes (TdP), a ventricular dysrhythmia that is lethal
when sustained (Gaur et al., 2009; Shryock et al., 2013; Chadda
et al., 2017). Thus, increases in ILATE above baseline by just 0.3%
to 1% predisposition to sudden cardiac death (Bennett et al.,
1995; Belardinelli et al., 2015). These observations underpin pro-
posals that inhibiting ILATE has therapeutic potential (Belardinelli
et al., 2006; Song et al., 2006).
We recently reported that the rapid influx of Na+ flux into
neurons in response to acute hypoxic challenge is due to
SUMOylation of NaV1.2, the major voltage-gated sodium chan-
nel in the brain; in that channel, SUMO modification of lysine
38 alters opening and closing with changes in voltage and
does not effect ILATE (Plant et al., 2016). SUMOylation is the
enzyme-mediated linkage of one of three SUMO isoforms to
the ε amino group of specific lysine residues in a target protein
(Henley et al., 2014). Present in all eukaryotic cells, the SUMO
pathway was known to regulate the trafficking and activity of nu-
clear transcription factors when we described it to operate as
well at the plasma membrane by direct SUMOylation of Na+
and K+ channels to regulate excitability (Rajan et al., 2005; Plant
et al., 2010, 2011, 2012, 2016; Xiong et al., 2017). Given the
important role of hypoxia-induced increases in ILATE in heart dis-
ease, we tested the hypothesis that SUMOylation of NaV1.5
channels was the underlying mechanism.
We demonstrate that hypoxia induces a rapid increase in
ILATE in human cardiac myocytes derived from pluripotent
stem cells (iPS-CMs). The response is reproduced by
application of cytosolic SUMO1 at ambient levels of oxygen
and suppressed by the deSUMOylating enzyme SENP1.
SUMOylation of NaV1.5 on lysine 442, a residue located in the
segment between channel domains I and II, is shown to be
necessary and sufficient to explain hypoxia-induced changes
in ILATE by reconstitution of the response in heterologous cells
and by studies using whole-cell and single-channel patch-
clamp recording and live cell Fo¨rster resonance energy transfer
(FRET). The implied mechanism was confirmed using total
internal reflection fluorescence microscopy (TIRFM) to study
single particles on the surface of live cells in real-time; the
time course was the same for hypoxic challenge, the recruit-
ment of SUMO1 to NaV1.5 channels on cell surface, and the
increase in ILATE. Furthermore, hypoxia-induced, SUMO-
dependent increases in ILATE were observed to increase APDorts 30, 2225–2236, February 18, 2020 ª 2020 The Author(s). 2225
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Acute Hypoxia and SUMO1
Augment the ILATE in Human iPS-CMs
INa in human iPS-CMs was studied by whole-cell
patch clamp. ILATEwas measured at30 mV and is
shown as a mean percentage of the peak current
remaining between 50 and 100 ms after the peak
current. Hypoxia challenge was a drop in O2 from
21% to 1.5%. The O2 level was measured in real
time in the recording chamber and fell from 21% to
1.5%O2 in 11 ± 3 s (not shown). The time course of
hypoxic modulation of INa was studied by steps
from –100 mV to 30 mV every 10 s. Whole-cell
currents were not studied for more than 600 s to
maintain consistent voltage clamp control of INa.
Cellswere studiedwith control solution (black), 1 nM
SUMO1 (red), or 1 nMSENP1 (blue) in the recording
pipette. Data are mean ± SEM for 8 to 10 cells per
group. Measured values and statistical analyses are
listed in Table 1.
(A) Left: example traces showing ILATE at 30 mV
increased when control perfusate at 21%O2 (black)
was exchanged with a hypoxic solution at 1.5% O2
(black dash). Inset: the increase in ILATE shown in response to hypoxia. Right: the time course for changes in ILATE in response to hypoxia and on return to normoxia
(21%). Scale bars represent 500 pA and 10 ms.
(B) Left: SUMO1 in the pipette (red) increased ILATE. No further change in ILATE was observed when the control perfusate was exchanged with a hypoxic solution at
1.5%O2 (red dash). Right: ILATEwas not observed with SENP1 in the pipette when cells were studied at 21% (blue) or 1.5%O2 (blue dash). In each case, the dashed
lines overlap with the solid lines.
(C) A histogram showing themean ILATE as a percentage of the peak current from cells studied at 21%O2 (solid color) after 200 s at 1.5%O2 (hatched color) and after
200 s following a return to 21% O2 (solid color) with control solution (black), 1 nM SUMO1 (red), or 1 nM SENP1 (blue) in the recording pipette.in human induced pluripotent stem cells (iPSCs) by recording
spontaneous action potentials in current-clamp mode; and
the changes were suppressed by ranolazine, a drug that
inhibits NaV1.5 channel late current. Incorporating the
measured hypoxia-induced increase in ILATE in iPS-CMs into
the O’Hara-Rudy model for human cardiac action potentials
(O’Hara et al., 2011) was sufficient to reproduce the observed
pro-arrhythmic increase in APD. Given the role of ILATE in
arrhythmogenesis, SUMOylation of NaV1.5 is identified as a
mechanistically defined target for therapeutic intervention.
RESULTS
Hypoxia Rapidly Increases ILATE in Human iPS-CMs
At ambient O2 levels (21%), INa in human iPS-CMs activated
rapidly to a mean peak of 40 ± 4 pA/pF when measured at
30 mV in whole-cell mode (Figure 1A; Table 1). INa then inac-
tivated to produce a residual ILATE that was 0.46% ± 0.1% of
the magnitude of peak current 50 to 100 ms after the onset of
inactivation. When O2 was lowered from ambient levels to
1.5% by the perfusion of cells with a hypoxic solution (Plant
et al., 2016), mean peak INa was unchanged (42 ± 3 pA/pF),
but ILATE increased 10-fold to 4.4% (1.85 pA/pF) of peak
INa after 100 s of hypoxia. The hypoxia-induced increase in
ILATE rose to half its maximal level in 40 ± 2 s and remained
stable for at least 3 min after iPS-CMswere restored to ambient
O2. Cells were not studied beyond 600 s to maintain consistent
voltage-clamp control of INa (Figure 1A). These changes are like
those observed in isolated rat ventricular myocytes (Ju et al.,
1996) and human cardiac muscle (Makielski, 2016; Wei et al.,
2016).2226 Cell Reports 30, 2225–2236, February 18, 2020SUMO1 Increases ILATE in Human iPS-CMs
We delivered 1 nM purified SUMO1 peptide into iPS-CMs by
the patch pipette; a concentration that evoked maximal
effects on NaV1.2 channels in cerebellar granule neurons
(CGNs) and three different K+ channels in CGNs, hippocam-
pal neurons, and rat cardiac myocytes (Xiong et al., 2017;
Plant et al., 2011, 2012, 2016). SUMO1 induced changes in
cardiac INa like those produced by hypoxia: ILATE increased
to 4.2% of peak INa without a change in the peak magnitude
(Figures 1B and 1C; Table 1). When SUMO1 was in the
recording pipette, changing the solution bathing iPS-CMs
from 21% to 1.5% O2 did not further alter the parameters
of INa peak or ILATE. The notion that hypoxic regulation of
INa proceeds by SUMOylation was further supported by the
observation that delivering 1 nM SENP1 deSUMOylase into
the iPS-CMs by the recording pipette suppressed the
increase in ILATE induced by hypoxia (Figures 1B and 1C;
Table 1).
ILATE is observed in the ‘‘window’’ between the voltages
where NaV channels activate and inactivate (Figure S1; Table 1).
Thus, exposure of the iPS-CMs to 1.5% O2 caused a leftward
shift in the half-maximal activation voltage of INa (V1/2-act) of
6 ± 4 mV and a rightward shift in the steady-state inactivation
midpoint (V1/2-SSI) of 6 ± 3mV, increasing the range of voltages
over which INa channels are likely to be activated but not fully
inactivated. In ambient O2, SUMO1 in the pipette increased
the magnitude of the window current in a manner like that
observed on exposure to 1.5% O2, and hypoxic challenge
with SUMO1 in the pipette did not further alter the parameters.
Furthermore, inclusion of 1 nM SENP1 prevented the effects
of hypoxia, maintaining the window current at control levels.
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.Of note, the kinetics of recovery of INa from the fast-inacti-
vated state was insensitive to hypoxia, SUMO1, and
SENP1 (Figure S1).
SUMOylation of NaV1.5 on Lys442 Is Necessary and
Sufficient to Recapitulate the Hypoxic Response
In cardiomyocytes, NaV1.5 channel complexes contain the
2016 amino-acid-pore-forming subunit (Figure 2A) and
an accessory subunit, NaVb1 (Catterall, 2012). A combination
of spectroscopic and electrophysiological assays in live CHO
cells showed that SUMOylation in response to hypoxia
occurred only on NaV1.5 K442 and that modification of the
site mediated the response to acute hypoxia.
First, the association of heterologously expressed human
NaV1.5 and SUMO proteins at the surface of cells was studied
bymeasuring FRET between subunits taggedwith the fluores-
cent proteins mTFP1 and YFP (Figure 2A). The NaVb1 subunit
was expressed in these studies but did not carry a fluorescent
protein. Tagging the N terminus of NaV1.5 (mTFP-NaV1.5) did
not alter the biophysical properties of the channel nor its
responsiveness to hypoxia or SUMO1 or SENP1 in the
recording pipette (Figures S2; Table S1). Similarly, tagging
the N terminus of SUMO1 (YFP-SUMO1) did not alter its oper-
ation with NaV1.5, as previously observed with NaV1.2 and
three K+ channels (Xiong et al., 2017; Plant et al., 2010,
2011, 2012, 2016).
Both mTFP1-NaV1.5 and YFP-SUMO1 were visualized at
the plasma membrane when expressed in CHO cells (Fig-
ure 2A). Indicating FRET, and thus the intimate association
of the two fluorophores consistent with SUMOylation, the
time course of mTFP1 photobleaching under continuous
illumination had a time constant (t) that was prolonged from
less than 10 s to 27 s when the channel was expressed with
YFP-SUMO1 (Figures 2B and 2C). mTFP-NaV1.5 also showed
FRET with YFP-Ubc9, the SUMO conjugating enzyme that
binds to target proteins onlywhen a lysine subject tomodifica-
tion is present (Xiong et al., 2017; Plant et al., 2016). In
contrast, FRET was not observed when mTFP-NaV1.5 was
expressed with linkage-incompetent YFP-SUMO195 (a variant
that lacks the terminal Gly-Gly motif present in SUMO1 and
the matured isoform SUMO197) or soluble YFP; in both cases,
t was less than 10 s.
To identify SUMOylation site(s) in NaV1.5 channels, we
analyzed the primary sequence of the subunit with an
algorithm that looks for variants of the canonical SUMO motif
c-K-X-E/D, as before with NaV1.2 and the K
+ channels (Xiong
et al., 2017; Plant et al., 2010, 2011, 2012, 2016). We mutated
each of five potential target lysines individually to glutamine in
mTFP-NaV1.5 and used FRET with YFP-SUMO1 to assess
interaction (Figure S2). Only K442, within the motif L-K442-K-
E, was required to produce FRET. Thus, mTFP-NaV1.5-
K442Q was expressed on the cell surface like wild-type
mTFP1-NaV1.5 but did not show FRET with YFP-SUMO1 or
YFP-Ubc9 (Figure 2C). The absence of FRET supported the
conclusion that K442 was necessary for SUMOylation of the
NaV1.5 channel complex and, moreover, that no other lysine
residue in the a subunit or in the NaVb1 was subject to
SUMOylation.Cell Reports 30, 2225–2236, February 18, 2020 2227
Figure 2. FRET between NaV1.5 and SUMO1
at the Cell Surface Requires K442
Human NaV1.5 was expressed with NaVb1 and
studied in live CHO-K1 cells per the STAR
Methods. FRET was assessed by measuring the
time constant (t) for mTFP photobleaching
(donor) in the presence of YFP (acceptor) from
3 regions of 5–7 cells per group. Data are mean
t ± SEM, and significant changes in t compared
to free YFP are indicated (*p < 0.001, two-way
ANOVA).
(A) Top: a cartoon showing the secondary
structure of a mTFP-NaV1.5 subunit and the
location of putative SUMOylation sites identified
by the SUMOplot algorithm. The NaV1.5 a-sub-
unit has four homologous domains (I–IV), each
with six transmembrane segments that fold to
form one central ion conduction pore. Domains I
and II are critical to opening the pore (activation)
(Catterall, 2017; Ceste`le et al., 1998, 2001). Fast
inactivation results from pore occlusion by an
IFM triplet of residues in the linker between
domains III and IV(Vassilev et al., 1988; West
et al., 1992; Cha et al., 1999). Bottom: fluores-
cent photomicrographs showing that mTFP-
NaV1.5 (blue) and YFP-SUMO1 (yellow) reach
the cell surface. Scale bar represents 10 mm. The
montage shows photobleaching of mTFP-NaV1.5
in response to continued excitation.
(B) Exemplar photobleaching studies show the
decay of mTFP fluorescence intensity for single
cells expressing mTFP-NaV1.5 (black circle) or
mTFP-NaV1.5-K442Q (green circle) with YFP-
SUMO1, fit by an exponential to give t.
(C) A histogram of mean FRET t values show the
assembly of mTFP-NaV1.5 (black bars) with YFP-
SUMO1 and YFP-Ubc9 (t = 28 ± 3* and 26 ± 3.5*,
respectively) but not with linkage-incompetent YFP-SUMO195 or free YFP (t = 9 ± 2 and 9 ± 2, respectively). In contrast, mTFP-NaV1.5-K442Q (green bars) did
not show FRET with YFP-SUMO1, YFP-SUMO195, YFP-Ubc9, or free YFP (t = 10 ± 2; 9.5 ± 2; 10 ± 2; and 9 ± 2, respectively).To confirm that K442 in the NaV1.5 sequence motif was
subject to SUMOylation, a mass spectrometry (MS) strategy
was used that we had previously developed for K+ channels
(Plant et al., 2010, 2011). SUMO197T95K, a variant that leaves
a Gly-Gly remnant of SUMO1 on the ε amino group of the target
Lys after enzyme cleavage, was expressed with NaV1.5
residues 353–502 bearing a His6 affinity tag and themammalian
E1 and E2 SUMOylation enzymes in bacteria. Affinity purifica-
tion followed by SDS-PAGE revealed a band of the expected
apparent mass for the NaV1.5-SUMO adduct (35 kDa). The
purified protein was treated with trypsin and subjected to MS
to yield a sequence coverage for NaV1.5353-502 of 42% and
was identified uniquely as the fragment carrying the Gly-Gly
SUMO1 remnant (Figure S4).
Next, we confirmed that K442 controlled the response to hyp-
oxia by studying human NaV1.5 channels expressed in CHO
cells. With the wild-type channel, decreasing O2 from 21% to
1.5% was associated with a rapid increase in ILATE from
0.5% (0.96 ± 0.2 pA/pF) to4.1% (8.3 ± 0.6 pA/pF), without
a change in the peak current,200 pA/pF at30 mV (Figure 3A;
Table 1), as observed for ILATE in iPS-CMs. As predicted, NaV1.5-
K442Q channels were insensitive to hypoxia; ILATE for the point2228 Cell Reports 30, 2225–2236, February 18, 2020mutant channels remained less than 0.5% of the peak
current when O2 was decreased to 1.5%. Furthermore, peak
current measured at 30 mV was like wild-type channels
(200 pA/pF) and was also unaltered by hypoxia (Figures 3A
and 3B). Of note, the time course for the change in ILATE for
NaV1.5 channels heterologously expressed in the CHO cells
was like that for native INa in iPS-CMs, increasing from 0.5 to
4.2% over 100 s, with half the rise time of 39.7 ± 2 s, and the
increase was stable after the cells were restored to ambient
levels of O2 for at least 3 min (Figure 3C).
NaV1.5 channels heterologously expressed in tissue culture
cells also responded to SUMO1 and SENP1 like INa in iPS-
CMs. Thus, NaV1.5 channels with SUMO1 in the recording
pipette showed ILATE of 4% of the peak current at both 21%
and 1.5%O2 (Figure 3C; Table 1). Furthermore, the window-cur-
rent voltages increased in 1.5% O2, or with 1 nM SUMO1,
by 6 mV for V1/2-act and +6 mV for V1/2-SSI (Figure S3), as
observed for INa in iPS-CMs. Also like INa in iPS-CMs, ILATE for
NaV1.5 channels was below 0.5%, with 1 nM SENP1 in the
pipette at both 21% and 1.5% O2, with no change in the window
current, V1/2-act, or V1/2-SSI. Finally, the biophysical properties
of NaV1.5-K442Q channels were insensitive to hypoxia and
Figure 3. K442 Is Required for Hypoxia and
SUMO1-Mediated ILATE
Human NaV1.5 wild-type (WT) or NaV1.5-K442Q
was expressed in CHO-K1 cells with NaVb1 and
studied under normoxic (21%) and hypoxic (1.5%)
O2 conditions with control solution (black), 1 nM
SUMO1 (red), or 1 nMSENP1 (blue) in the recording
pipette, as indicated. The late current (ILATE) was
studied at 30 mV and is shown as a mean per-
centage of the peak current remaining between 50
and 100 ms after the peak current. The time course
of hypoxic modulation of INa was studied by steps
from –100mV to30mV every 10 s. Data are mean
± SEM for 8 to 12 cells per group. Single-channel
currents were studied in cell-attached mode and
elicited every 5 s by a 50-ms depolarizing pulse to
–30 mV from a holding potential of –120 mV. Data
were recorded at filter and sampling frequencies of
5 and 50 kHz, respectively, and processed offline
using a 1.2-kHz Bessel filter for display. Recording
pipettes were filled with extracellular buffer. For
each cell, null sweeps (with no channel activity) were
identified, averaged offline, and subtracted from the
data sweeps before analysis.
(A) Example traces from a cell expressing WT
NaV1.5 channel activation at 30 mV; ILATE
increased when control perfusate at 21%O2 (black)
was exchanged with a hypoxic solution at 1.5% O2
(black dash). Inset: the increase in ILATE shown in
response to hypoxia.
(B) Example traces showing that hypoxia does not
induce an increase in ILATE in cells expressing
NaV1.5-K442Q channels.
(C) Left: the time course for changes in ILATE in
response to hypoxia and on return to normoxia for
cells expressing WT NaV1.5 (closed circles) or
NaV1.5-K442Q channels (open circles) with control
solution (black), SUMO1 (red), or SENP1 (blue) in the
recording pipette. Right: a histogram showing the
mean ILATE as a percentage of the peak current from
cells studied at 21%O2, after 200 s at 1.5%O2 and
after 200 s following a return to 21% O2, with the
pipette solutions indicated.
(D) Top: upon depolarization, single NaV1.5
channels opened, inactivated rapidly, and did not
reopen. NaV1.5 channels reopened upon exposure to 1.5%O2. Null traces in normoxia and hypoxia were 55% ± 5% (n = 20 patches; 2,000 sweeps) and 53% ± 4%
(n = 20 patches; 2,000 sweeps), respectively. Bottom: ensemble average traces (n = 200–220 sweeps) for the condition indicated.
(E) Top: single NaV1.5-K442Q channels did not reopen in ambient or hypoxic conditions. Null traces were 51% ± 3% (n = 20 patches; 2,000 sweeps) and 50% ± 2%
(n = 20 patches; 2,000 sweeps), respectively. Bottom: ensemble average traces (n = 200–225 sweeps) for the condition indicated.were not altered by SUMO1 or SENP1, showing less than 0.5%
ILATE and without changes in V1/2-act and V1/2-SSI.
Single NaV1.5 Channels Are Reopened from the Inactive
State by Hypoxia
Single NaV1.5 channels are closed at rest, open briefly upon
depolarization, and then inactivate rapidly; the channels remain
in the inactive state until the membrane returns to the resting
potential and the channels move back to the closed state from
which they are available to open once again in response to the
next heartbeat. Thus, single NaV1.5 channels in cell-attached
patches open just once in response to depolarization and almost
always remain inactive (Figure 3D). As predicted by their
behavior in whole-cell mode, hypoxia induced abnormal sin-gle-channel reopenings during sustained depolarization.
Ensemble currents generated by the cumulative averaging of
300 repetitive cycles of depolarization demonstrated that the
reopening of inactivated NaV1.5 channels in response to hypoxia
was sufficient to increase ILATE from 0.4% ± 0.1% to 4.8% ±
0.3%. In contrast, NaV1.5-K442Q channels opened only once
and remained inactive when cells were studied in either ambient
levels of O2 or at 1.5% O2 (Figure 3E).
Single NaV1.5 Channels Are Reopened from the Inactive
State by SUMOylation
To confirm the mechanistic role of SUMO, single NaV1.5 chan-
nels were studied in inside-out membrane patches excised
from CHO cells, allowing perfusion of the intracellular face ofCell Reports 30, 2225–2236, February 18, 2020 2229
Figure 4. Hypoxia Recruits One SUMO1 Monomer to Each Cell Surface NaV1.5 Channel
SinglemTFP-NaV1.5 channels (blue) and SUMO1 taggedwithmCherry (m-SUMO1, red) were studied in CHO-K1 cells by TIRFM. Stoichiometric (photobleaching)
and pixel-by-pixel analysis for subunit density and co-localization were performed as described in the STARMethods. Manders’ coefficients were assessed post
hoc for 3–5 regions per cell, and co-localization was defined as the presence of both fluorophores at more than 30% of the maximum fluorescence level recorded
in that stack (and their overlap is represented in the images as white pixels). The time course of hypoxic modulation of NaV1.5 ILATE was studied with steps from
–100 mV to 30 mV every 10 s and normalized to the peak current. Data represent 5–8 cells, and biophysical parameters and single particle statistical analyses
are summarized in Tables S1 and S3.
(A) Left: single co-localized particles with mCherry and TFP fluorescence were observed at the surface of cells expressing NaV1.5 and SUMO1. The time courses
for simultaneous photobleaching of the fluorophores revealed that complexes have one subunit of each type.
(B) Histogram of photobleaching steps showing that hypoxia increased single m-SUMO1 (red) subunits at the cell surface co-localized with mTFP-NaV1.5
channels (blue), without a change in subunit stoichiometry.
(legend continued on next page)
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the channel with experimental solutions. In ambient O2, single
NaV1.5 channels opened once and remained inactive for the
duration of the depolarizing step, and in this configuration
reducing O2 from 21% to 1.5% did not produce channel reopen-
ing (Figure S5). This suggested that hypoxia-induced reopening
in whole-cell mode depended on the presence of cytoplasmic
SUMO, a hypothesis confirmed when patches were perfused
with 1 nM SUMO1, and reopening was observed at both 21%
and 1.5% O2.
Like the changes observed in whole-cell mode with hypoxia,
single channels in the patches reopenedwithin 150 s of exposure
to SUMO1, with 50% of the patches showing channel reopening
at 65 ± 10 s (Figure S5). In agreement with the cell-attached
recordings, ensemble currents generated from single NaV1.5
channels by averaging 500 cycles of depolarization in off-cell
patches showed that SUMO1 increased ILATE from 0.4% ±
0.2% to 4.1% ± 0.3% (Figure S5). As anticipated, single
NaV1.5-K442Q channels in inside-out patches opened once
and did not reopen even when exposed to SUMO1 or hypoxia
(Figure S5). When considered in conjunction with the cell-
attached studies, these findings support three conclusions:
SUMOylation is necessary and sufficient for aberrant reopening
of single NaV1.5 channels, K442 is required to mediate the effect
of SUMO1 on NaV1.5, and hypoxia-evoked changes in ILATE are
mediated by the SUMO pathway.
Hypoxia Induces Rapid monoSUMOylation of NaV1.5
Channels
To determine the stoichiometry of SUMOylation, we directly
counted the number of SUMO1 monomers on individual
NaV1.5 channels at the surface of live CHO cells by using TIRFM
photobleaching, as before for NaV1.2 and IKs channels (Xiong
et al., 2017; Plant et al., 2014, 2016). When mTFP-NaV1.5 and
SUMO1 tagged with mCherry (m-SUMO1) were co-expressed,
particles containing only mTFP-NaV1.5 and others with both
mTFP-NaV1.5 and m-SUMO1 were observed at the cell mem-
brane (Figures 4A and 4B; Table 2). Approximately 10% of
mTFP-NaV1.5 channels were co-localized with one m-SUMO1
in ambient oxygen: continuous, two-color excitation bleached
each fluorophore in the complexes in a single step consistent
with one subunit of each type. On exposure to hypoxia,
m-SUMO1 was recruited to the cell surface but only at sites
with mTFP-NaV1.5, increasing the number of pixels that con-
tained both mTFP-NaV1.5 and m-SUMO1 channels from 10%
to 87% within 100 s (Figure 4B). Increased co-localization
did not alter the 1:1 stoichiometry of NaV1.5 channel and
m-SUMO1 complexes, as judged by bleaching.(C) Left: the images show that in ambient O2, the surface density of m-SUMO1 (to
hypoxia recruits m-SUMO1 to the cell surface within 100 s (top), where it is c
observed to change (middle). The scale bar represents 10 mm.
(D) Histogram of surface density summarizing six cells studied as described in (A).
and 305 ± 21 for NaV1.5 (blue). The density of pixels with both fluorophores (green
mm2 and decreased the density of free NaV1.5 channels (37 ± 4) without altering
(E) The time course for the hypoxia-induced increase in the co-localization of mTF
of ILATE, as a percentage of the peak current (open circle) were coincident. Amean
0.03 in 100 s of exposure to hypoxia. The mean ILATE rose from 0.46% ± 0.1%
peak current ratio were unchanged for at least 3 min after cells were restored toEvidence that the co-localization represented a covalent inter-
action of the channel and SUMO1 was provided by two addi-
tional experiments (Figure S6). First, m-SUMO1 was not
observed at the membrane in cells expressing mTFP-NaV1.5-
K442Q and rarely yielded co-localization of the fluorophores in
21% or 1.5% O2. Second, hypoxia did not increase the number
of particles at the membrane with m-SUMO195, the SUMO1
variant that is unable to covalently attach to target lysines.
Because NaV1.5 channels contain just one a-subunit, the
observed 1:1 stoichiometry with SUMO1 supports three addi-
tional conclusions: NaV1.5 subunits are SUMOylated only on
K442, the channel is monoSUMOylated and polySUMO1 chains
were not observed, and the NaVb1 subunit is not SUMOylated.
Although hypoxia recruitedm-SUMO1 to the cell surface, it did
not change the number of NaV1.5 channels at the plasma mem-
brane (Figures 4C and 4D; Table 2). This was shown by studying
the surface density and localization of mTFP-NaV1.5 and m-
SUMO1 subunits by using pixel-by-pixel analysis, a method
we have applied before (Xiong et al., 2017; Plant et al., 2014,
2016). In ambient O2, about 10% of mTFP-NaV1.5 fluorescent
pixels were localized with m-SUMO1 (33 ± 3/mm2) and 90% of
the channels were unmodified (305 ± 21/mm2). After 100 s of
hypoxia, the ratio was reversed; the number of mTFP-NaV1.5
pixels co-localized with m-SUMO1 increased to about 90%
(301 ± 13/mm2), and 10% of the channels remained unmodified
by m-SUMO1 (37 ± 4/mm2). Thus, hypoxia increased the surface
density of m-SUMO1 33-fold (from 10/mm2 to 334/mm2),
whereas the density of mTFP-NaV1.5 did not change (338/mm
2).
Consistent with cause and effect, the appearance of
m-SUMO1 at the plasmamembranewith mTFP-NaV1.5, demon-
strated above to require covalent modification of the channel on
K442, matched the time course of hypoxia-induced increase
in ILATE observed in iPS-CMs and NaV1.5 channels studied in
CHO cells (Figures 1 and 3; Table 1). These rates also matched
the increase in the mean Manders’ coefficient of co-localization
of m-SUMO1 and mTFP-NaV1.5 (Figure 4E) as well as Pearson’s
correlation coefficient (Table S2). Also, as observed for ILATE in
iPS-CMs and NaV1.5 channels in CHO cells, the number of
mTFP-NaV1.5 surface particles and the fraction of channels
localized with m-SUMO1 were stable on restoration to ambient
O2 for 3 min after hypoxia (Figure 4E; Table 2). Supporting the
notion that heterologous expression of m-SUMO1 increased
basal SUMOylation of mTFP-NaV1.5, about 10% of mTFP-
NaV1.5 channels co-localized with m-SUMO1 in these cells
and ILATE was 2.5-fold higher (1% of peak current) than the
control in ambient O2, rising to 4.5% with hypoxia (Tables 1
and S1).p) is low compared to NaV1.5 (middle) with little co-localization (bottom). Right:
o-localized with NaV1.5 channels (bottom); surface levels of NaV1.5 were not
In ambient O2, the density of pixels per mm
2 with SUMO1 alone (red) was 3 ± 1,
) was 33 ± 3 per mm2. Hypoxia increased co-localization to 301 ± 13 pixels per
the density of free SUMO1 (6 ± 2).
P-NaV1.5 andm-SUMO1 (Manders’ coefficient, black circle) and themagnitude
Manders’ coefficient of 0.10 ± 0.01measured in ambient O2 increased to 0.91 ±
to 4.4% ± 0.8%. Increases in the Manders’ coefficient and late current versus
ambient O2.
Cell Reports 30, 2225–2236, February 18, 2020 2231
Table 2. Co-localization of SUMO1 with Nav1.5 in Response to Hypoxia
Subunits Expressed mTFP-NaV1.5 + m-SUMO1 mTFP-NaV1.5-K442Q + m-SUMO1
Condition
Ambient
O2
Hypoxia
50 s
Hypoxia
100 s
Recovery
150 s
Ambient
O2
Hypoxia
50 s
Hypoxia
100 s
Recovery
150 s
Single particle stoichiometry
SUMO1: NaV1.5
1: 1 1: 1 1: 1 1: 1 0: 1 0: 1 0: 1 0: 1
Free mTFP-NaV1.5, pixels/mm
2 305 ± 21 166 ± 18* 37 ± 4** 39 ± 5** 328 ± 26 333 ± 29 326 ± 25 308 ± 19
Free m-SUMO1, pixels/mm2 3 ± 1 4 ± 2 7 ± 2 5 ± 2 3 ± 1 4 ± 1 4 ± 2 6 ± 2
Co-localized pixels/mm2 33 ± 3 179 ± 15** 301 ± 13** 302 ± 15** 4 ± 1 4 ± 2 3 ± 1 4 ± 1
NaV1.5 or NaV1.5-K442Q subunits tagged with mTFP1 were expressed in CHO-K1 cells with mCherry-SUMO1 (m-SUMO1) and studied by TIRFM and
whole-cell patch clamp (Figures 3 and 5). The number of photobleaching steps observed for each fluorophore in each single fluorescent spot reports
on the stoichiometry of the channel complex. NaV1.5 channels are monomers and show no more than one bleaching step when tagged with mTFP1
(Figure 5). No more than one bleaching steps was observed for mCherry-tagged SUMO1 subunits (free or co-localized with the channel). A 1:1 stoi-
chiometry is maintained when cells are exposed to hypoxia (1.5% O2). SUMO1 was not observed to co-localize with NaV1.5-K442Q channels. The
surface density of subunits was quantified as the mean of four 100- by 100-pixel regions for 6–10 cells per group. Exposure to hypoxia increased
the number of SUMO1 monomers observed at the cell surface within 100 s, and almost all were co-localized with NaV1.5. Data are mean ± SEM
for 5 to 8 cells per group; * p < 0.05, **p < 0.01 compared with cells studied in ambient O2 for each channel type.Hypoxia-Induced ILATE in iPS-CMs Yields SUMO-
Dependent APD Prolongation
To evaluate if the increase in ILATE we observed was sufficient to
produce pro-arrhythmic APD prolongation, iPS-CMs were stud-
ied in current-clamp mode and the time to repolarize the mem-
brane to resting values during spontaneous action potentials
was measured. Under control conditions, the cells had a resting
potential of 45 ± 3 mV, and the phase 1 action potential up-
stroke mediated by INa peaked at 43 ± 4 mV (n = 6). Hypoxia
increased the time for 50% restoration (APD50) by 22% without
changing the resting potential or the action potential height (Fig-
ure 5A). To confirm that action potential prolongation was due to
an increase in ILATE, we applied ranolazine, an open-state
blocker of NaV1.5 channels in clinical use that preferentially in-
hibits ILATE rather than peak INa (Maier and Sossalla, 2013).
Ranolazine reversed hypoxia-induced lengthening of APD50 to
within 5%of control values without altering other action potential
biophysical parameters (Table S3).
To verify that SUMOylation mediates hypoxia-induced APD
prolongation, 1 nM SUMO1 or SENP1 was included in the
recording pipette. As expected, SUMO1 lengthened APD50 to
123% of control values without causing a significant shift in the
resting membrane potential or the height of spontaneous action
potentials in 21% O2, and hypoxia evoked only a further 5%
increase in the APD50 (Figure 5B). Subsequent application of
ranolazine reversed the effects of SUMOylation as it had the
effects of hypoxia with control solution in the pipette, reducing
APD50 to within 5% of its control value. In contrast, 1 nM
SENP1 in the recording pipette yielded APD50, resting mem-
brane potential, and action potential height like control cells
studied in 21% O2, and neither hypoxia nor ranolazine altered
the three parameters of excitability (Figure 5C). These observa-
tions support the conclusion that hypoxia-induced changes in
APD are primarily due to the SUMO-mediated increase in ILATE
passed by NaV1.5 channels. Of note, baseline APD in iPS-CMs
is longer than that in native cardiomyocytes, apparently due to
a lower expression of K+ channels (Yang et al., 2014).
The O’Hara-Rudy model for human cardiac action potentials
was used to demonstrate that the increase in ILATE due to2232 Cell Reports 30, 2225–2236, February 18, 2020SUMOylation of NaV1.5 channels observed in reconstituted
CHO cells and iPS-CMs was sufficient to meet the theoretical
requirements for pro-arrhythmic prolongation of APD. As
anticipated, the time to repolarize the membrane from peak to
rest by 50% (APD50) was prolonged by 27% when ILATE was
increased in the model by 5-fold, half the observed maximal
effect in the cells, from 205 ms under control conditions to
260 ms (Figure 5D); also as observed in iPS-CMs, there was
no appreciable change in the resting membrane potential or
the action potential peak current in the model (Table S3).
DISCUSSION
Myocardial hypoxia increases ILATE leading to increased APD, a
common setting for dangerous arrhythmias. Here, we show that
hypoxia induces SUMOylation of NaV1.5 channels on K442 and
this is necessary and sufficient to increase ILATE and APD in
human cardiomyocytes. Supporting a direct mechanism,
SUMOylation of NaV1.5 produces ILATE in the absence of hypoxia
in membrane patches excised from cells, basal levels of NaV1.5
SUMOylation are low under control conditions in iPS-CMs, and
hypoxia leads to SUMOylation of the channels with the same
time course as the increase in ILATE. Furthermore, SUMOylation
produces changes in the gating of single NaV1.5 ion channels,
macroscopic INa, and APDs like those described in human heart
and in animal models with hypoxia (Chadda et al., 2017; Austen
et al., 1963; Thung et al., 1962; Brown et al., 2014); and the
effects are suppressed by the mutation of NaV1.5 K442, the
application of SENP1 deSUMOylase, or the application of
ranolazine, an inhibitor of ILATE.
Increased ILATE and AP prolongation predispose to arrhythmia
because they increase the influx of Na+, raising the intracellular
Na+ concentration and depolarizing the membrane potential.
These changes impact the activity of other ion channels and trans-
porters, including the Na/K-ATPase, leading to Ca2+ loading by
L-type Ca2+ channel reactivation and reverse operation of
the sodium-calcium exchanger (NCX). These excitatory effects
increase the likelihood of early after-depolarizations (EADs),
delayed after-depolarizations (DADs), triggered activity, and
Figure 5. Hypoxia-Induced Increase in APD Mediated by SUMO
Modulation of ILATE
Spontaneous action potentials from human iPS-CMs were recorded in current-
clamp mode with the same sequence of perfusates: normoxic (21% O2, solid
line), hypoxic (1.5% O2, dashed line), and then hypoxia with 1 mM ranolazine
(purple). Action potentials were studied with control intracellular solution (black)
or with 1 nM SUMO1 (red) or SENP1 (blue) in the recording pipette. APD50 was
determined by calculating the time required for themembrane potential to return
to 50% of the resting value from the peak deflection of the action potential.
Hypoxia was induced as described in the STAR Methods. Data are means ±
SEM for 6–9 cells studied per group (*p < 0.01, two-way paired t test). The
O’Hara-Rudymodel for human action potentials was applied as described in the
STARMethods and Table S3. Scale bars represent 25 mV and 250 ms in (A)–(C)
and 30 mV and 150 ms in panel (D).
(A) Examplar spontaneous action potentials recorded from iPS-CMs studied
with control pipette solution under normoxic conditions and hypoxia with and
without ranolazine. The APD50 increased with hypoxia by 22%, from 663 ± 2 ms
to 810 ± 2 ms, and application of ranolazine restored the APD50 to 689 ± 2 ms.
(B) When SUMO1 was included in the pipette solution, APD50 was 822 ± 2 ms,
and this increased to 870 ± 2 ms with hypoxia; ranolazine with hypoxia pro-
duced an APD50 of 699 ± 3ms like that observedwithout SUMO1 in the pipette
under normoxic conditions.
(C) APD50 was 663 ± 2mswhen cells were studied with SENP1 in the recording
pipette, and the APD50 increased only to 698 ± 2 ms with hypoxia and was
returned to 663 ± 4 ms with ranolazine.
(D) When a 5-fold increase in ILATE (half the maximal effect observed with
hypoxia/SUMOylation), was simulated using the O’Hara-Rudy model, the
APD50 increased by 27%, from 205 ms in normoxia to 260 ms.
(E) Histograms summarizing the mean APD50 of iPS-CMs under the conditions
described in (A)–(C).spatiotemporal changes in repolarization that promote reentrant
arrhythmias, including ventricular TdP (Gaur et al., 2009; Shryock
et al., 2013; Chadda et al., 2017). Medications like ranolazine that
suppress ILATEminimize disruptionofCa
2+ homeostasis, reducing
EADs andDADs (Maier and Sossalla, 2013). The hypoxic increase
in ILATE we observe with iPS-CMs modeled in the O’Hara-Rudy
algorithm are found sufficient to underlie the increase in APD
that induces these downstream effects (Figure 5). In addition to
hypoxia and ischemia (Saint, 2006; Hammarstro¨m and Gage,
2002), cardiac ILATE is reported to increase with oxidative stress
(Ward and Giles, 1997), acidosis (Plant et al., 2006), heart failure
(Valdivia et al., 2005; Undrovinas et al., 2006), and inflammation
(Ward et al., 2006), suggesting a role for SUMOylation in the trans-
duction of these stimuli that merits study.
Rapid SUMOylation of NaV1.5 channels on the cardiac plasma
membrane in response to hypoxia is reminiscent of our finding
that hypoxia mediates SUMOylation of NaV1.2 channels on the
surface of central neurons in under 60 s on K38, leading to an
increase peak current (without changes in ILATE) due to changes
in the voltage dependence of activation, consistent with early,
rapid Na+ flux in cerebral ischemia, a prelude to downstream
pathology (Plant et al., 2016). In both cases, rapid recruitment
of SUMO in the first few minutes of hypoxia initiates deleterious
sequelae. In contrast, chronic hypoxia has been associated with
cardioprotection by increased SUMOylation of the ATPase
SERCA2A in heart failure and ischemia-reperfusion injury (Du
et al., 2018) and with neuroprotection by a global increase in
SUMOylation, changes in gene expression, and remodeling of
protein expression in ground squirrel hibernation torpor (Kho
et al., 2011, 2015; Lee et al., 2007) and chronic oxygen-glucose
deprivation (Lee et al., 2009).
NaV1.5 is recognized as the preeminent sodium channel in the
heart, although other voltage-gated sodium channels are
expressed at lower levels and in specific cardiac regions (Maier
et al., 2004), notably purkinje fibers (Haufe et al., 2005). Although
non-NaV1.5 channels (Maier et al., 2004) have been described as
contributing only 5%–10% of peak current, a role for hypoxia-
induced ILATE is possible because non-NaV1.5 currents have
been implicated in the late currents measured with ambient
oxygen in isolated canine and murine myocytes (Biet et al.,
2012; Yang et al., 2012). We do not infer roles for NaV1.2,
NaV1.1, or NaV1.6 in SUMO-mediated hypoxic late current
because we have demonstrated that the stimuli alter peak
current and do not induce ILATE with NaV1.2 in rat CGN and
CHO cells and that NaV1.1 and NaV1.6 channels are insensitive
to SUMOylation in rat hippocampal neurons and rat CGN,
respectively (Plant et al., 2016). We cannot rule out contributions
from NaV1.3, NaV1.4, NaV1.7, NaV1.8, or NaV1.9.
At the single-channel level, the abnormal increases in ILATE we
observe with hypoxia are like those recorded with mutations in
NaV1.5 that cause LQT3 that destabilize internal pore occlusion
by the IFM inactivation ‘‘lid’’ that resides between channel
domains III and IV (Bennett et al., 1995; West et al., 1992). Rather
than a single opening followed by inactivation, the LQT3
channels re-open with maintained depolarization, suggesting a
lowered energetic barrier for return to the open state. Consistent
with the idea that SUMOylated NaV1.5 channels also experience
potentials where the energetic barriers to moving between theCell Reports 30, 2225–2236, February 18, 2020 2233
open and inactive states are lowered, we observe hypoxia to
increase the window between activation and steady-state
inactivation voltage curves (Figure S3). Furthermore, our failure
to observe long first openings suggests that the barrier to
inactivation is not increased by hypoxia. Of note, destabilization
of the inactivated state can rationalize ILATE in association with
channels that recover from inactivation too rapidly during repo-
larization (Belardinelli et al., 2006, 2015; Shryock et al., 2013).
It is feasible that hypoxia-induced SUMOylation of NaV1.5 on
K442, a site on the linker between domains I and II, may interfere
with the stability of the interaction of the IFM lid and its pore
receptor.
Here, we apply SUMO1101 to the inner surface of excised
membrane patches to SUMOylate NaV1.5 channels, as we
observed before for K2P1, KV2.1, and NaV1.2 channels; this
indicates that enzymes stably associated with the cytoplasmic
face of the plasma membrane mature SUMO1 to SUMO97 and
mediate coupling to target lysine (Xiong et al., 2017; Plant
et al., 2010, 2011, 2012, 2016). In contrast, when SUMOylation
of NaV1.5 channels is induced by hypoxia, the membrane must
be in continuity with the cytosol, indicating cellular components
have a role in transducing the signal that oxygen tension is low to
the SUMO pathway. Thus far, exogenous SENP1 must be
applied to deSUMOylate the ion channels in off-cell mode in all
cases we have studied.
It is notable that changes in Ca2+ homeostasis are not required
for hypoxia-induced SUMOylation of NaV1.5 in whole cells as the
reaction proceeds despite 10 mM EGTA in the recording pipette
to suppress changes in cellular Ca2+ and 200 mM CdCl2 in the
extracellular bath solution to suppress conductance through
voltage-gated calcium channels (Figure 1A). The similar
attributes of SUMOylated NaV1.5 currents in intact cells and sin-
gle channels in excised patches also support the conclusion that
changes in Ca2+ at the cytoplasmic face of the channel are not
necessary for SUMO-induced increases in ILATE (Figure S5).
Those points do not rule out a role for variation in cytoplasmic
Ca2+ when the ionic concentration is not clamped by chelation
and blockade.
Ion channel SUMOylation appears to enhance excitability by
decreasing potassium currents (K2P1, KV2.1, and Kv7.1/
KCNE1) (Rajan et al., 2005; Plant et al., 2010, 2012) or increasing
currents passed by NaV1.2 (Plant et al., 2016) and NaV1.5 (this
work). Our prior study showing that acute hypoxia leads to the
rapid SUMOylation of NaV1.2 in CGN and influx of Na
+ flux due
to altered voltage-dependent gating (but not a change in ILATE)
(Plant et al., 2016) and this study of NaV1.5 suggest that hypox-
ia-mediated SUMOylation is an emerging common mechanism
shared by some, but not all, ion channels.
We observed previously that acidosis increases ILATE in
NaV1.5 channels bearing a common polymorphism associated
with SIDS and arrhythmia in African American adults, presenting
a model for the genetic predisposition to dysrhythmia in the face
of an environmental challenge (Plant et al., 2006). Inherited ion
channel mutations that predispose to arrhythmia by increasing
APD also yield life-threatening events in response to specific
stimuli, for example, concurrent drug blockade (Sesti and Gold-
stein, 1998). Here, we present the mechanism for the sensitivity
of wild-type NaV1.5 channels to the environmental challenge of2234 Cell Reports 30, 2225–2236, February 18, 2020hypoxia. Identifying the role of the SUMO pathway in the in-
crease in ILATE in response to hypoxia supports targeting the
pathway for therapeutic intervention.STAR+METHODS
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Further Information and requests for resources and reagents should be directed to the LeadContact, S.A.N. Goldstein (sgoldst2@uci.
edu). Materials generated through this work are available from the Lead Contact upon reasonable request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
CHO-K1 cells (RRID: CVCL_0214) were obtained from ATCC and used for heterologous expression, as detailed below. Human
induced pluripotent stem cell cardiomyocytes2 were purchased fromCellular Dynamics and cultured on #1.5 glass coverslips coated
with gelatin (0.1% w/v in water) according to the manufacturer’s instructions. Cells were maintained in iCell maintenance medium
(Cellular Dynamics) and incubated at 37C in a humidified atmosphere containing 5% CO2 / 95% air (21% O2). The iPS cells were
studied between days 5 - 10 in culture at which time both isolated cells and cells in syncytia exhibited rhythmic beating behavior,
a criterium for mature myocyte attributes shown to correspond with expression of troponin-T and sarcomeric a-actinin (Ma et al.,
2011). To further verify that the currents under study in iPS cells were mediated by NaV1.5 channels, we employed protocols andCell Reports 30, 2225–2236.e1–e4, February 18, 2020 e1
solutions to minimize conductance through potassium and calcium channels (per Figures 1, S1, and 5); showed that the currents had
biophysical hallmarks like those of human NaV1.5 in tissue culture cells (per Table 1 and Figures 3 and S3); and demonstrated
blockade with ranolazine, a drug that inhibits ILATE mediated by NaV1.5 (per Table S3 and Figure 5).
METHOD DETAILS
Molecular Biology and Reagents
HumanNaV1.5 (NM_198056.1) was handled in pcDNA1, as previously described (Plant et al., 2006) andwas transiently cotransfected
with GFP-tagged SCN1B (the b subunit of cardiac SCN5A channel, isoform b; GenBank: NM_001037). Human SUMO1101 (GenBank:
NM_003352.8) and Ubc9 (GenBank: NM_003345.5) were amplified from a brain cDNA library (Clontech) and inserted into pMAX, as
described before (Rajan et al., 2005). Sequences encoding mCherry or mTFP1 were inserted as described (Plant et al., 2010) at the
N terminus of SUMO1 or NaV1.5 respectively. SUMO1 and Ubc9 were tagged with eYFP using the same strategy. Mutations were
introduced with Pfu Quikchange PCR (Agilent). Purified SUMO197, SUMO293, SENP1 and SENP2 were purchased from Boston
Biochemical.
Heterologous Expression
CHO-K1 cells (RRID: CVCL_0214) were maintained in F12K medium supplemented with 10% FBS. Plasmids were transfected into
cells with Lipofectamine 2000 according to the manufacturer’s instructions (Life Technologies). Experiments were performed 24 to
48 hours post transfection at room temperature. The human b1 accessory subunit was co-expressed with NaV1.5 subunits unless
otherwise indicated.
Electrophysiology
INa and action potentials in iPS-CMs, and whole-cell NaV1.5 channel currents in heterologous cells were recorded using an Axopatch
200B amplifier and pCLAMP software (Molecular Devices) at filter and sampling frequencies of 10 and 50 kHz respectively. For
voltage-clamp studies, cells were superfused with a solution comprising, in mM: NaCl 130, CsCl 4, CaCl2 2, MgCl2 1.2, glucose
5.5, HEPES 10 and, 200 mM CdCl2, a concentration previously shown to block >98% of voltage-gated calcium channel current in
primary cells (Pearson et al., 1993). The pH was adjusted to 7.4 with NaOH and HCl. Cells were studied at room temperature with
borosilicate glass pipettes (Clark Kent) with a resistance of 2-3 MU when filled with a solution comprising, in mM: CsCl 60, CsF
80, CaCl2 1, MgCl2 1, Na2ATP 5, EGTA 10, HEPES 10, pH 7.4 with CsOH. Pipettes were coated with Sylgard (Dow Corning) prior
to use. Capacitance artifacts were subtracted online, series resistance was compensated to 70% and cells with a series resistance
of less than 10MUwere studied. Once whole-cell mode was established, cells were not studied for more than 600 s in order to main-
tain consistent membrane seals and voltage-clamp control of INa. Current-voltage relationships were evoked from a holding potential
of 100 mV by 100 ms test pulses between 100 and 0 mV, in 10 mV increments. Steady-state inactivation was studied by holding
cells at 140 mV and then comparing currents evoked by 50 ms test pulses between 140 mV and 20 mV to those evoked by a
100 ms prepulse to 0 ms. A 10 s interpulse interval was used in both cases. Normalized peak current values are plotted against
prepulse potential (mV). A Boltzmann function, I = Imax/(1 + exp[V – V1/2/k]), where Imax is the maximum current and k is slope factor,
was used to fit normalized activation-voltage relationships. Recovery from fast inactivation was studied by holding cells at100 mV
and comparing currents evoked by a pair of 50 ms test step to30 mV separated by an interpulse interval that increased in duration
by 5 ms increments per sweep. The time constant for recovery from inactivation (t) was obtained from mono-exponential fits of the
normalized current amplitude to the recovery time using It = Imax +A½et=t , where A is the amplitude of components and t is time.
Whole-cell currents were normalized to cell capacitance. Mean ± SEM capacitance values were 28 ± 5 pF for iPS cells and 10 ±
2 pF for CHO cells.
For current-clamp studies, iPS-CMs were superfused with a solution comprising, in mM: NaCl 135, KCl 3.5, CaCl2 2, MgCl2 1.2,
glucose 8, HEPES 10 and the pHwas adjusted to 7.4. The intracellular solution contained, in mM: KCl 140, MgCl2 2, Na2ATP 5, EGTA
1, HEPES 5 and the pH was adjusted to 7.4.
Acute Hypoxia for Electrophysiology
Acute hypoxia was achieved as described previously (Plant et al., 2002). Briefly, the cells were made hypoxic (1.5%O2) by switching
the perfusate with one that had been bubbled with nitrogen for at least 30 minutes prior to perfusion. Oxygen tension was measured
at the cell by a polarized carbon fiber electrode; solution exchange occurred in less than 10 s. Ambient O2, or normoxia recording
conditions, were achieved by allowing recording solutions to equilibrate with room air for at least 30 minutes prior to perfusion.
The ambient O2 solution was measured to be 21% O2 at the cell. All solutions were equilibrated, measured, and perfused at room
temperature (18C).
Two-Color TIRFM
Single protein complexes at the surface of live CHO-K1 cells were identified using TIRFM as previously described (Plant et al., 2014).
Cells were studied in a solution comprising (in mM): NaCl 130, KCl 4, MgCl2 1.2, CaCl2 2, HEPES 10, pH was adjusted to 7.4 with
NaOH. The critical angle for TIRF was adjusted using a CellTIRF illuminator (Olympus) and a high numerical aperture apochromat
objective (150x, 1.45 NA) mounted on an automated fluorescence microscope (IX81) controlled by Metamorph software (Molecular
Devices). For simultaneous illumination of two fluorophores, CellTIRF software (Olympus) was used to adjust the critical angle for
each excitation wavelength to generate evanescent waves of equivalent depth (100 nm). mCherry was excited by a 561-nm laser
line and mTFP1 was excited a 445-nm laser line. When mTFP1 was studied with mCherry the emitted light signals were split usinge2 Cell Reports 30, 2225–2236.e1–e4, February 18, 2020
a 520-nm dichroic mirror mounted in a DualView adaptor (Photometrics) and each wavelength was directed to one half of an
EM-CCD. The dichroic mirror was disengaged when single fluorophores were studied.
To assess stoichiometry, fluorophores were photobleached by continual excitation and data were captured as movies of 100-400
frames acquired at 1 Hz using an EM-CCD camera (Hamamatsu). When mTFP1 was studied with mCherry in the same cell, the data
for each fluorophore were saved as separate stacks and processed in an identical manner. Images were background corrected by
subtracting the mean of 5 fully bleached frames from the end of each stack analyzed. Misalignment of the data between stacks was
corrected in ImageJ using StackReg. Fluorescent spots were defined as a discrete 3 3 3-pixel region around a pixel of maximum
intensity, as before (Plant et al., 2010, 2014). Fluorescence is reported as the change in fluorescence intensity normalized by the initial
fluorescence for each trace. The density of co-localized and single fluor-fluorescent particles was determined following thresholding
and watershed separation in ImageJ. The particle number was counted in 4, separate 100 3 100-pixel regions of interest for 6-10
cells per group using the Analyze particles plugin.
Manders’ coefficient of colocalization was assessed from live-cell simultaneous two-color TIRF images captured at 5 s intervals to
minimize photobleaching. Data stacks were background subtracted and aligned prepared for each fluorophore post hoc, as above.
Co-localization of partner pixels from the two stacks of images was defined as the presence of both fluorophores with at least 30%
of maximum fluorescence levels recorded in that region of interest. Mean Manders’ coefficients were calculated for 3-5 separate
100 3 100-pixel regions of interest per cell.
Live Cell FRET Microscopy
Donor-decay time-course was studied as before (Plant et al., 2010), using an Olympus inverted epi-fluorescence microscope. Cells
were studied in a solution comprising (in mM): NaCl 130, KCl 4, MgCl2 1.2, CaCl2 2, HEPES 10, pH was adjusted to 7.4 with NaOH.
mTFP1 was excited at 445 nm and the emission collected through a 470-500 nm bandpass filter, YFP was excited at 514 nm and the
emission collected through a 525-575 nm filter. Images were captured using a scientific camera controlled by mmanager or
Metamorph software (Molecular Devices) and were analyzed with ImageJ.
Mass Spectrometry
Human NaV1.5 residues 353-502 were cloned into pET28a vector with six-His residues and a tobacco etch virus (TEV) cleavage site
replacing the thrombin site and expressed in BL21(DE3) E. Coli with a vector carrying mouse E1 (as a linear fusion product of Aos1
and Uba2), E2 (Ubc-9) and SUMO11-97 with a T95Kmutation so that trypsin digestion before MS leaves a Gly-Gly tag on the ε-amino
group of target lysines as before (Plant et al., 2010). Protein was purified with Ni-NTA affinity columns. The eluate was reduced with
TCEP and alkylated using iodoacetamide prior to tryptic digestion via filter-assisted digestion. LC MS/MS analysis was performed
using a Thermo Scientific Dionex UltiMate 3000 system coupled in-line to an Orbitrap Fusion Lumos MS. A 25 cm x 75 mm PepMap
EASY-Spray Acclaim PepMap C18 Column was used to separate peptides over acetonitrile gradients of 4% to 28% at a flow rate of
300 nL/min. Each duty cycle consists of one MS scan in FT mode (350-1500 m/z, resolution of 120,000 at m/z 400) followed by data-
dependent tandem mass scans in IT mode for 3 s at top speed, utilizing HCD with NCE 30% on the most intense ions with charge
states +2 or higher. The RAWdata file acquiredwas extracted toMGF format usingMSConvert (http://proteowizard.sourceforge.net/
tools.shtml) and subjected to database searching using Batch-Tag within a developmental version of Protein Prospector (v. 6.1.0)
against a decoy database consisting of a normal Homo sapiens Swissprot database concatenated with a randomized version
(SwissProt.2019.4.8.random.concat, total 20,418 protein entries). The mass accuracy for parent ions and fragment ions were set
as ± 10 ppm and 0.2 Da, respectively. Trypsin was set as the enzyme and maximum of two missed cleavages were allowed. Protein
N-terminal acetylation, methionine oxidation, Gly-Gly, and N-terminal conversion of glutamine to pyroglutamic acid were selected as
variable modifications. Minimum protein and peptide scores were set as 22.0 and 5.0 respectively, while maximum E values for
proteins and peptides were set to 0.01 and 0.1. A list of identified precursor ions corresponding to peptides carrying GlyGly
modifications were generated for targeted sequencing for further validation. All MS/MS spectra for potential SUMOylated peptides
were further inspected manually and evaluated based on spectral quality.
Simulations
Action potentials were simulated using the O’Hara Rudy (ORD) model (O’Hara et al., 2011) under normal condition or by scaling the
conductance of ILate. To simulate the effect of SUMO (or hypoxia-induced SUMOylation) a scaling factor named ‘‘SUMO’’ that varies
from 1 (No SUMO) to 10 (maximum effect at 1 nMSUMO1) was added to themodel to increase the conductance of Ilate:GNalate SUMO =
GNaLate  SUMO, were GNaLate is the nominal conductance value from theO’Hara-Rudy ventricular myocytemodel andGNalate SUMO is
the conductance used for simulation in the modified ORD. Other variables and all equations of the model were otherwise
as described in the published model, except that the external ionic concentrations were set to match the experimental
conditions used here to study the iPS-CMs (in mM): [Na+]o = 135; [Ca
2+]o = 2.0; and [K
+]o = 3.5. A pacing cycle length of 800 ms
was used and the numbers of beats was set to 1000. The duration of the APD50 was measured from the time of maximum dV/dt
to the time that membrane voltage reached 50% of complete repolarization; resting potential was measured immediately before
each beat.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed using pClamp, Origin, GraphPad and Excel software. Quantification and analysis specific in each experimental
technique is described in the Method Details section, above. Data were assessed for statistical differences between groups byCell Reports 30, 2225–2236.e1–e4, February 18, 2020 e3
one-way analysis of variance with Bonferroni post hoc analysis to test differences within pairs of group means for all dataset with an
F-value of p < 0.05. Data are presented, where indicated as the mean ± standard error of the mean (SEM). The number of replicates
for each study are described in the legends.
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